Dannappel Marius Volker, Sooraj Dhanya, Loh Jia Jian, Firestein Ron
Hudson Institute of Medical Research, Clayton, VIC, Australia.
Department of Molecular and Translational Sciences, Monash University, Clayton, VIC, Australia.
Front Cell Dev Biol. 2019 Jan 14;6:171. doi: 10.3389/fcell.2018.00171. eCollection 2018.
CDK8 and its paralog, CDK19, collectively termed 'Mediator Kinase,' are cyclin-dependent kinases that have been implicated as key rheostats in cellular homeostasis and developmental programming. CDK8 and CDK19 are incorporated, in a mutually exclusive manner, as part of a 4-protein complex called the Mediator kinase module. This module reversibly associates with the Mediator, a 26 subunit protein complex that regulates RNA Polymerase II mediated gene expression. As part of this complex, the Mediator kinases have been implicated in diverse process such as developmental signaling, metabolic homeostasis and in innate immunity. In recent years, dysregulation of Mediator kinase module proteins, including CDK8/19, has been implicated in the development of different human diseases, and in particular cancer. This has led to intense efforts to understand how CDK8/19 regulate diverse biological outputs and develop Mediator kinase inhibitors that can be exploited therapeutically. Herein, we review both context and function of the Mediator kinases at a molecular, cellular and animal level. In so doing, we illuminate emerging concepts underpinning Mediator kinase biology and highlight certain aspects that remain unsolved.
细胞周期蛋白依赖性激酶8(CDK8)及其旁系同源物CDK19统称为“中介体激酶”,它们是细胞周期蛋白依赖性激酶,被认为是细胞稳态和发育编程中的关键调节因子。CDK8和CDK19以互斥的方式整合到一个名为中介体激酶模块的四蛋白复合物中。该模块与中介体可逆性结合,中介体是一种由26个亚基组成的蛋白质复合物,可调节RNA聚合酶II介导的基因表达。作为该复合物的一部分,中介体激酶参与了多种过程,如发育信号传导、代谢稳态和先天免疫。近年来,包括CDK8/19在内的中介体激酶模块蛋白的失调与多种人类疾病尤其是癌症的发生发展有关。这促使人们努力去了解CDK8/19如何调节多种生物学输出,并开发可用于治疗的中介体激酶抑制剂。在此,我们在分子、细胞和动物水平上综述了中介体激酶的背景和功能。通过这样做,我们阐明了支撑中介体激酶生物学的新出现的概念,并突出了某些尚未解决的方面。